Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$1.09 - $1.9 $19,511 - $34,010
-17,900 Reduced 48.25%
19,200 $22,000
Q1 2024

May 07, 2024

BUY
$1.4 - $2.55 $51,940 - $94,605
37,100 New
37,100 $56,000
Q4 2022

Feb 14, 2023

SELL
$3.53 - $5.49 $21,886 - $34,038
-6,200 Reduced 7.53%
76,100 $325,000
Q3 2022

Nov 14, 2022

BUY
$3.74 - $7.09 $227,766 - $431,781
60,900 Added 284.58%
82,300 $381,000
Q2 2022

Aug 15, 2022

BUY
$4.33 - $7.45 $8,660 - $14,900
2,000 Added 10.31%
21,400 $131,000
Q1 2022

May 16, 2022

BUY
$5.84 - $13.61 $12,264 - $28,581
2,100 Added 12.14%
19,400 $113,000
Q4 2021

Feb 14, 2022

BUY
$12.52 - $19.02 $17,528 - $26,628
1,400 Added 8.81%
17,300 $224,000
Q3 2021

Nov 15, 2021

SELL
$10.47 - $20.87 $310,959 - $619,839
-29,700 Reduced 65.13%
15,900 $217,000
Q2 2021

Aug 11, 2021

BUY
$13.9 - $22.58 $633,840 - $1.03 Million
45,600 New
45,600 $974,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $26.1M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.